跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,472 条关于
“Relapsing-Remitting MS”
全部
3,472
临床试验
2,468
药物
208
机构
4
资讯
792
14小时前
CHMP Backs Roche's Ocrevus for Pediatric Relapsing MS, Citing 48% Relapse Reduction
去年
Real-World Discontinuations of Ocrelizumab in MS Comparable to Pivotal Trials
去年
Study Evaluates Recurrence of Disease Activity After Ocrelizumab Discontinuation in MS Patients
去年
CLARION Study: Harmonizing Data Quality in Multiple Sclerosis Registries for Long-Term Safety Monitoring of Cladribine Tablets
去年
Hope Biosciences' Stem Cell Therapy Shows Promise in Phase II MS Trial
去年
SetPoint Medical's Neuroimmune Modulation Platform Receives FDA IDE Approval for Relapsing-Remitting MS Trial
去年
Dr. Reddy's Siponimod Tablets Recommended for Marketing Approval in India for SPMS Treatment
去年
Hope Biosciences' Stem Cell Therapy Shows Promise in Phase 2 MS Trial
去年
TG Therapeutics to Present New BRIUMVI Data in Multiple Sclerosis at ACTRIMS 2025 Forum
11个月前
Octave Bioscience Receives Grant to Develop World's First Blood Test for Multiple Sclerosis Progression
第 1 页,共 80 页
上一页
下一页